Published in Rev Neurol (Paris) on October 01, 2001
[An enlightened psychotic?]. Rev Neurol (Paris) (2003) 0.75
Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat Genet (1999) 4.74
Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell (1998) 4.41
Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q. Nature (1990) 3.77
Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain (2005) 2.88
Autopsies of sudden infant death syndrome--classification and epidemiology. Acta Paediatr (1995) 2.75
Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. Hum Mol Genet (2000) 2.40
Congenital muscular dystrophy with merosin deficiency. C R Acad Sci III (1994) 2.22
The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain (2005) 2.17
Paramedian thalamic and midbrain infarct: clinical and neuropathological study. Ann Neurol (1981) 2.10
A simple, effective and well-tolerated treatment regime for West syndrome. Dev Med Child Neurol (1994) 2.07
Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci U S A (2000) 1.97
Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. Brain (2001) 1.82
Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients. Neurology (1994) 1.79
Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol (1996) 1.77
Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet (2000) 1.76
Neuromyelitis optica in France: a multicenter study of 125 patients. Neurology (2010) 1.75
Bilateral parasagittal parietooccipital polymicrogyria and epilepsy. Ann Neurol (1997) 1.72
Pyridoxine dependent epilepsy: a suggestive electroclinical pattern. Arch Dis Child Fetal Neonatal Ed (1999) 1.69
The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment. Brain (2009) 1.65
Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults. J Inherit Metab Dis (2007) 1.64
Migrating partial seizures in infancy: a malignant disorder with developmental arrest. Epilepsia (1995) 1.60
Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat Genet (2000) 1.58
Early epileptic encephalopathy with suppression bursts and olivary-dentate dysplasia. Neuropediatrics (1992) 1.55
Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis. J Neurol Neurosurg Psychiatry (1999) 1.55
[Acute poisoning by carbon monoxide and heating gases]. Rev Prat (1979) 1.54
Antiepileptic drugs as a cause of worsening seizures. Epilepsia (1998) 1.52
Electroencephalographic aspects of hemimegalencephaly. Dev Med Child Neurol (1989) 1.51
Neuromyelitis optica and pregnancy. Neurology (2012) 1.49
Calcitonin gene-related peptide, a peptide present in spinal cord motoneurons, increases the number of acetylcholine receptors in primary cultures of chick embryo myotubes. Neurosci Lett (1986) 1.49
Linkage of a new locus for autosomal dominant familial spastic paraplegia to chromosome 2p. Hum Mol Genet (1994) 1.49
Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy. Neurology (2003) 1.45
Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler (2007) 1.45
doublecortin is the major gene causing X-linked subcortical laminar heterotopia (SCLH). Hum Mol Genet (1998) 1.44
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria. J Neurol Neurosurg Psychiatry (1997) 1.44
Human skeletal muscle sodium channelopathies. Neurol Sci (2005) 1.43
IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Genes Immun (2008) 1.43
[Benign intracranial hypertension and minocycline]. Rev Neurol (Paris) (1988) 1.42
X-linked malformations of neuronal migration. Neurology (1996) 1.42
Hereditary thermosensitive neuropathy: an autosomal dominant disorder of the peripheral nervous system. Neurology (1997) 1.42
Giant cell arteritis and Vernet's syndrome. Neurology (1998) 1.39
Phenytoin administration in the newborn and infant. Brain Dev (2000) 1.38
Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res (1997) 1.37
Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia (1998) 1.37
Evidence for a serum-factor secreted by the human thymus. Lancet (1972) 1.30
Brown-Vialetto-Van Laere syndrome in a large inbred Lebanese family: confirmation of autosomal recessive inheritance? Am J Med Genet (2000) 1.28
The right brain hemisphere is dominant in human infants. Brain (1997) 1.27
FDG-PET improves surgical outcome in negative MRI Taylor-type focal cortical dysplasias. Neurology (2010) 1.25
New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis. Neurology (2004) 1.25
Changes in regional cerebral blood flow during brain maturation in children and adolescents. J Nucl Med (1992) 1.23
Blood levels of diazepam after single rectal administration in infants and children. J Pediatr (1978) 1.22
Devastating epileptic encephalopathy in school-aged children (DESC): a pseudo encephalitis. Epilepsy Res (2006) 1.21
Paramyotonia congenita: genotype to phenotype correlations in two families and report of a new mutation in the sodium channel gene. J Neurol Sci (1996) 1.21
Mutation analysis of the paraplegin gene (SPG7) in patients with hereditary spastic paraplegia. Neurology (2006) 1.20
ClC-1 chloride channel mutations in myotonia congenita: variable penetrance of mutations shifting the voltage dependence. Hum Mol Genet (1998) 1.20
Cephaloceles: clinical and neuroradiological appearance. Associated cerebral malformations. Neuroradiology (1983) 1.20
Early diagnosis of severe myoclonic epilepsy in infancy. Brain Dev (1992) 1.17
Neuropsychological aspects of tuberous sclerosis in relation to epilepsy and MRI findings. Dev Med Child Neurol (1991) 1.16
Diffuse cortical dysplasia, or the 'double cortex' syndrome: the clinical and epileptic spectrum in 10 patients. Neurology (1991) 1.15
Pharmacokinetics of the individual enantiomers of vigabatrin (gamma-vinyl GABA) in epileptic children. Br J Clin Pharmacol (1990) 1.13
Subcortical laminar heterotopia and lissencephaly in two families: a single X linked dominant gene. J Neurol Neurosurg Psychiatry (1994) 1.12
Neonatal myasthenia gravis: a new clinical and immunologic appraisal on 30 cases. Neurology (1988) 1.12
A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis. Arch Neurol (2001) 1.11
Regulation of muscle AChR alpha subunit gene expression by electrical activity: involvement of protein kinase C and Ca2+. Neuron (1989) 1.11
The G526R glycyl-tRNA synthetase gene mutation in distal hereditary motor neuropathy type V. Neurology (2006) 1.11
Peripheral neuropathy and inborn errors of metabolism in adults. J Inherit Metab Dis (2007) 1.11
Electrophysiological properties of the hypokalaemic periodic paralysis mutation (R528H) of the skeletal muscle alpha 1s subunit as expressed in mouse L cells. FEBS Lett (1996) 1.11
Neuropsychiatric aspects of tuberous sclerosis. Ann N Y Acad Sci (1991) 1.08
Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France. Br J Haematol (2001) 1.08
Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients. Epilepsy Res (2000) 1.08
Infantile spasms in Down syndrome--effects of delayed anticonvulsive treatment. Epilepsy Res (2003) 1.08
The phenotype of "pure" autosomal dominant spastic paraplegia. Neurology (1994) 1.07
Calcium currents and transients of native and heterologously expressed mutant skeletal muscle DHP receptor alpha1 subunits (R528H) FEBS Lett (1998) 1.07
Encephalopathy with calcifications of the basal ganglia in children. A reappraisal of Fahr's syndrome with respect to 14 new cases. Neuropediatrics (1989) 1.07
Reappraisal of Rasmussen's syndrome with special emphasis on treatment with high doses of steroids. J Neurol Neurosurg Psychiatry (1994) 1.06
Phenotype of autosomal dominant spastic paraplegia linked to chromosome 2. Brain (1996) 1.06
Mutations in the mitochondrial glutamate carrier SLC25A22 in neonatal epileptic encephalopathy with suppression bursts. Clin Genet (2009) 1.05
Early single photon emission computed tomography in Sturge-Weber syndrome. J Neurol Neurosurg Psychiatry (1997) 1.02
HTLV-I, brain abnormalities on magnetic resonance imaging, and relation with multiple sclerosis. Lancet (1987) 1.02
Prophylactic antiepileptic treatment in Sturge-Weber disease. Seizure (2002) 1.02
Severe neonatal episodic laryngospasm due to de novo SCN4A mutations: a new treatable disorder. Neurology (2010) 1.01
Core-rod myopathy caused by mutations in the nebulin gene. Neurology (2009) 1.01
Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases. J Med Genet (2005) 1.01
Cognitive function in recent-onset demyelinating diseases. Arch Neurol (1986) 1.01
Accelerated myelination in early Sturge-Weber syndrome: MRI-SPECT correlations. Pediatr Radiol (1996) 0.99
[Ventricular staphylococcal infections. Treatment with vancomycin by continuous venous infusion]. Presse Med (1986) 0.99
Immaturity of muscle fibers in the congenital form of myotonic dystrophy: its consequences and its origin. J Neurol Sci (1988) 0.98
Infantile phytanic acid storage disease, a possible variant of Refsum's disease: three cases, including ultrastructural studies of the liver. J Inherit Metab Dis (1982) 0.98
[Carbon monoxide poisoning and acute anoxia due to inhalation of coal gas and hydrocarbons: 302 cases, 273 treated by hyperbaric oxygen at 2 ata]. Ann Med Interne (Paris) (1969) 0.98
Decreased expression of the mitochondrial matrix proteases Lon and ClpP in cells from a patient with hereditary spastic paraplegia (SPG13). Neuroscience (2008) 0.98
Therapeutic trial of vigabatrin in refractory infantile spasms. J Child Neurol (1991) 0.98
Novel muscle chloride channel (CLCN1) mutations in myotonia congenita with various modes of inheritance including incomplete dominance and penetrance. Neurology (1998) 0.97
EFNS guidelines on the molecular diagnosis of mitochondrial disorders. Eur J Neurol (2009) 0.97
[Continuous partial epilepsy: syndrome and disease]. Rev Neurol (Paris) (1982) 0.96